| CAMX | ROE | CAMX / ROE | |
| Gain YTD | 5.351 | 16.252 | 33% |
| Net Assets | 57.2M | 162M | 35% |
| Total Expense Ratio | N/A | 0.49 | - |
| Turnover | 70.00 | 51.00 | 137% |
| Yield | 0.50 | 0.98 | 51% |
| Fund Existence | 18 years | 2 years | - |
| CAMX | ROE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | N/A |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 61% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 90% |
| Advances ODDS (%) | N/A | 4 days ago 88% |
| Declines ODDS (%) | N/A | 10 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 80% | 3 days ago 80% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNIX | 81.53 | 0.73 | +0.90% |
| Janus Henderson Global Life Sciences I | |||
| SFPAX | 11.27 | 0.09 | +0.81% |
| Saratoga Financial Service A | |||
| IVIFX | 21.87 | 0.13 | +0.60% |
| Macquarie International Core Eq C | |||
| MCSDX | 37.88 | 0.17 | +0.45% |
| NYLI WMC Enduring Capital Class R6 | |||
| NELIX | 68.25 | 0.07 | +0.10% |
| Nuveen Equity Long/Short I | |||
A.I.dvisor indicates that over the last year, CAMX has been closely correlated with TEL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CAMX jumps, then TEL could also see price increases.
| Ticker / NAME | Correlation To CAMX | 1D Price Change % | ||
|---|---|---|---|---|
| CAMX | 100% | N/A | ||
| TEL - CAMX | 67% Closely correlated | -0.34% | ||
| GS - CAMX | 66% Loosely correlated | +3.54% | ||
| PPG - CAMX | 62% Loosely correlated | +1.65% | ||
| AXP - CAMX | 60% Loosely correlated | +0.71% | ||
| SHEL - CAMX | 60% Loosely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, ROE has been closely correlated with APO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROE jumps, then APO could also see price increases.